Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

BMS and Sanofi seek U.S. and European approval for clopidogrel

May 8, 1997

Genentech plans phase III studies of second-generation t-PA

May 7, 1997

Positive clinical results for desirudin in the prevention of thromboembolism

May 5, 1997

Vascular Therapeutics reports positive safety and efficacy profile for Vasoflux

April 28, 1997

Orally active antiplatelet agents disclosed by Mitsui Toatsu

April 22, 1997

Stable prostacyclins disclosed by Asahi Glass

April 21, 1997

Factor Xa inhibitors from Boehringer Mannheim

April 18, 1997

New fibrinogen antagonist from DuPont Merck

April 17, 1997

DuPont Merck presents new thrombin inhibitor

April 17, 1997

Novel aggregation pathway identified

April 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...